Model DetailsLung carcinoma
Model Name |
Lung carcinoma | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
lung, bronchiolo-alveolar carcinoma • lung carcinoma • lung alveolar-bronchiolar carcinoma • lung carcinoma metastasis to bronchial lymph node • pulmonary carcinoma |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Male |
14.6% (31 of 213 mice) |
120 weeks |
|
Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
| Lung | Female |
7.0% (15 of 213 mice) |
120 weeks |
|
Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
| Lung | Female |
6.7% (1 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Female |
6.25% (2 of 32 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Female |
5.5% (4 of 73 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Female |
5.9% (1 of 17 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Female |
3.1% (8 of 258 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| (Unspecified organ) | Female |
37.5% (3 of 8 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
13.3% (2 of 15 mice) |
24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
20% (3 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
21.1% (4 of 19 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
6.4% (3 of 47 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
23.5% (8 of 34 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
28.6% (2 of 7 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
12.5% (1 of 8 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
9.5% (2 of 21 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
31.25% (5 of 16 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
50% (4 of 8 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
13.9% (34 of 245 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| (Unspecified organ) | Male |
14.7% (5 of 34 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Lung | Male |
observed |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Lung | Male |
observed |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Lung | Mixed Population |
observed |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Lymph node | Mixed Population |
0.04% (2 of 5065 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Lung | Male |
5.03% (128 of 2543 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Lung | Female |
1.51% (38 of 2522 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |
| Lung | Mixed Population |
3.28% (166 of 5065 mice) |
94-114 weeks |
|
Ward JM, J Natl Cancer Inst 1979 Sep;63(3):849-54 |